| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |